Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Friday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

Shares of MTEX opened at $7.30 on Friday. Mannatech has a 1 year low of $7.30 and a 1 year high of $15.10. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.07 and a quick ratio of 0.51. The stock’s fifty day moving average price is $8.39 and its two-hundred day moving average price is $8.64. The firm has a market cap of $13.76 million, a PE ratio of -6.08 and a beta of 1.18.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Thursday, March 28th. The company reported ($0.94) earnings per share for the quarter. The business had revenue of $32.69 million during the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.